feed,title,long_url,short_url
MarketWatch,BioMarin's stock falls 27% after FDA asks for additional data about experimental hemophilia A drug,http://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/SAXkJ6qSizA/story.aspx,https://j.mp/3gfaGWy
